{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:44:42Z","timestamp":1791409482872,"version":"4.3.3"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Invasive pneumococcal disease (IPD) is associated with significant morbidity and mortality in children. Universal pneumococcal conjugate vaccination has changed the epidemiology of IPD. In vaccinated children, IPD can be a marker of an underlying immunodeficiency.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This is a retrospective audit of children younger than 18 years with IPD admitted to 2 tertiary pediatric hospitals in Australia between 2011 and 2017. Data on predisposing conditions, immunologic evaluation, pneumococcal serotype, antibiotic susceptibility and treatment were collected.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>During the 7-year period, there were 131 presentations with IPD in 127 children; 3 children had recurrent IPD. Patients presented with sepsis (41%), empyema (29%), meningitis (18%), mastoiditis (12%), pneumonia (10%) and septic arthritis (4%). In 19 (15%) presentations, risk factors for IPD were present, including malignancy, hematologic disorder, chronic liver disease, chronic kidney disease and cochlear implant. Pneumococcal serotypes were determined in 78\/131 (60%) of presentations: the most frequent serotypes were 19A (19%), 3 (13%), 7F (10%) and 19F (8%) and non-vaccine serotypes 22F (8%), 35B (6%), 15A (4%) and 38 (4%). Overall, 11% of isolates were non-susceptible to ceftriaxone. Only 36 patients (32%) had an immunologic evaluation, and 4 patients had proven or probable immunodeficiency.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Although pneumococcal conjugate vaccine serotypes 19A, 3, 19F and 7F remain frequent causes of IPD, non-vaccine serotypes are emerging. Our data support vancomycin treatment for children with pneumococcal meningitis given 11% of our isolates were not susceptible to ceftriaxone. It is important to consider underlying conditions predisposing to IPD in a population with high rates of pneumococcal vaccination.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002489","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T16:17:58Z","timestamp":1575908278000},"page":"1-6","source":"Crossref","is-referenced-by-count":14,"title":["Changing Epidemiology and Predisposing Factors for Invasive Pneumococcal Disease at Two Australian Tertiary Hospitals"],"prefix":"10.1097","volume":"39","author":[{"given":"Hayley","family":"Hernstadt","sequence":"first","affiliation":[{"name":"Department of Paediatric Infectious Diseases, St Mary\u2019s Hospital, Imperial College Healthcare Trust, London, United Kingdom"},{"name":"Department of General Medicine, Royal Children\u2019s Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Cheung","sequence":"additional","affiliation":[{"name":"Department of Immunology, Women\u2019s and Children\u2019s Hospital, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hurem","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Paediatrics, Women\u2019s and Children\u2019s Hospital, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Vasilunas","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Women\u2019s and Children\u2019s Hospital, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linny Kimly","family":"Phuong","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Royal Children\u2019s Hospital Melbourne, Victoria, Australia"},{"name":"Murdoch Children\u2019s Research Institute, Royal Children\u2019s Hospital Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Quinn","sequence":"additional","affiliation":[{"name":"Department of Immunology, Women\u2019s and Children\u2019s Hospital, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Paediatrics, Women\u2019s and Children\u2019s Hospital, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Daley","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Royal Children\u2019s Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Cole","sequence":"additional","affiliation":[{"name":"Department of Immunology, Royal Children\u2019s Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Gwee","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Royal Children\u2019s Hospital, Melbourne, Victoria, Australia"},{"name":"Murdoch Children\u2019s Research Institute, Royal Children\u2019s Hospital Melbourne, Victoria, Australia"},{"name":"Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199710023371404","article-title":"Bacterial meningitis in the United States in 1995. Active surveillance team.","volume":"337","author":"Schuchat","year":"1997","journal-title":"N Engl J Med"},{"key":"R4-20230912","first-page":"CD004405","article-title":"Corticosteroids for acute bacterial meningitis.","volume":"9","author":"Brouwer","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20230912","first-page":"E267","article-title":"Invasive pneumococcal disease in Australia 2011 and 2012.","volume":"40","author":"Toms","year":"2016","journal-title":"Commun Dis Intell Q Rep"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ijid.2009.05.010","article-title":"Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.","volume":"14","author":"Isaacman","year":"2010","journal-title":"Int J Infect Dis"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/INF.0000000000000701","article-title":"Immunodeficiency among children with recurrent invasive pneumococcal disease.","volume":"34","author":"Ingels","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/cid\/ciu274","article-title":"Invasive pneumococcal disease in children can reveal a primary immunodeficiency.","volume":"59","author":"Gaschignard","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics.","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cid\/ciy129","article-title":"Effectiveness of 7- and 13-valent pneumococcal conjugate vaccines in a schedule without a booster dose: a 10-Year Observational Study.","volume":"67","author":"Jayasinghe","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"e0177113","DOI":"10.1371\/journal.pone.0177113","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: a systematic review and meta-analysis.","volume":"12","author":"Balsells","year":"2017","journal-title":"PLoS One"},{"key":"R16-20230912","first-page":"E267","article-title":"Invasive pneumococcal disease in Australia, 2011 and 2012.","volume":"40","author":"Toms","year":"2016","journal-title":"Commun Dis Intell Q Rep"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12879-015-1147-x","article-title":"Pneumococcal serotype evolution in Western Europe.","volume":"15","author":"Tin Tin Htar","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"suppl_1","key":"R18-20230912","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1093\/ofid\/ofx162.158","article-title":"Direct and indirect impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) among children and adults in the U.S.","volume":"4","author":"Pilishvili","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study.","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1542\/peds.2007-2017","article-title":"Streptococcus pneumoniae\u2013associated hemolytic uremic syndrome: classification and the emergence of serotype 19A.","volume":"125","author":"Copelovitch","year":"2010","journal-title":"Pediatrics"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijantimicag.2013.07.017","article-title":"Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009-2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and \u03b2-lactam resistance.","volume":"42","author":"Lee","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/INF.0b013e31803df9ca","article-title":"Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.","volume":"26","author":"Pelton","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","article-title":"Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.","volume":"32","author":"Davis","year":"2013","journal-title":"Vaccine"},{"issue":"suppl 2","key":"R26-20230912","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1097\/INF.0000000000000084","article-title":"Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization.","volume":"33","author":"Loo","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination.","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"R28-20230912","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/INF.0000000000001845","article-title":"Characteristics of children with invasive pneumococcal disease after the introduction of the 13-valent pneumococcal conjugate vaccine in England and Wales, 2010-2016.","volume":"37","author":"Makwana","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.2009-2150","article-title":"Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use.","volume":"126","author":"Pilishvili","year":"2010","journal-title":"Pediatrics"},{"key":"R30-20230912","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1542\/peds.2014-2426","article-title":"Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease.","volume":"135","author":"Yildirim","year":"2015","journal-title":"Pediatrics"},{"key":"R31-20230912","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1016\/j.vaccine.2014.03.017","article-title":"Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.","volume":"32","author":"van Hoek","year":"2014","journal-title":"Vaccine"},{"issue":"suppl 2","key":"R32-20230912","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1097\/INF.0000000000000079","article-title":"Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity.","volume":"33","author":"Deloria Knoll","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R35-20230912","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis.","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R36-20230912","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/pch\/19.3.141","article-title":"Guidelines for the management of suspected and confirmed bacterial meningitis in Canadian children older than one month of age.","volume":"19","author":"Le Saux","year":"2014","journal-title":"Paediatr Child Health"},{"issue":"suppl 3","key":"R37-20230912","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","article-title":"ESCMID guideline: diagnosis and treatment of acute bacterial meningitis.","volume":"22","author":"van de Beek","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R38-20230912","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1128\/AAC.05658-11","article-title":"Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study.","volume":"56","author":"Kim","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R39-20230912","doi-asserted-by":"crossref","first-page":"e0210520","DOI":"10.1371\/journal.pone.0210520","article-title":"Spread of ceftriaxone non-susceptible pneumococci in South Korea: long-term care facilities as a potential reservoir.","volume":"14","author":"Choi","year":"2019","journal-title":"PLoS One"},{"key":"R40-20230912","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/jac\/dkr048","article-title":"Predominance of ST320 among Streptococcus pneumoniae serotype 19A isolates from 10 Asian countries.","volume":"66","author":"Shin","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R41-20230912","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/377534","article-title":"An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome.","volume":"37","author":"Yu","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R42-20230912","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/00006454-200010000-00018","article-title":"Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.","volume":"19","author":"Olivier","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R44-20230912","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2334-12-181","article-title":"Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?","volume":"12","author":"Marchese","year":"2012","journal-title":"BMC Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:23:45Z","timestamp":1694557425000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002489","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}